
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Sponsored
Sponsored
2026-08-13RVPHWSCHEDULE 13G/ABarclays PLC Reports Nominal Position in Reviva Pharmaceuticals Holdings, Inc.
Barclays PLC has filed a Schedule 13G/A (Amendment No. 1) with the SEC, reporting a nominal position in Reviva Pharmaceuticals Holdings, Inc. (ticker: RVPHW). As of the event date of June 30, 2026, Barclays PLC beneficially owns 20 shares of common stock, representing a 0.00% ownership stake in the company. This filing...
Biotechnologyownership +0.00%
Sponsored